Drug
Cdx 110 With GM Csf
Cdx 110 With GM Csf: highest development phase Phase 2, developed by Celldex Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Celldex Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CDX-110 with GM-CSF NCT00458601 | Phase 2 | Malignant Glioma |
Latest
No recent events.
Follow Cdx 110 With GM Csf on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.